Localized Recurrence Is Rare In An Isolated Fashion
Jose A. Karam, MD, FACS Associate Professor Departments of Urology and Translational Molecular Pathology Discusses Localized Recurrence Is Rare In An Isolated Fashion. At Kidney Cancer Association Nat...
Author: kidneycancer
Added: 10/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Sequencing Immunotherapies In Kidney Cancer
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses Sequencing Immunotherapies In Kidney Cancer. At Kidney Cancer Association Nationa...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Ipilimumab & Nivolumab Combo
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses Ipilimumab & Nivolumab Combo. At Kidney Cancer Association National Patient and C...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
First Line Therapy In cMRCC
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses First Line Therapy In cMRCC. At Kidney Cancer Association National Patient and Ca...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Combo Avelumab & Axitinib
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses Combo Avelumab & Axitinib. At Kidney Cancer Association National Patient and Care...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Combinations In Anti VEGF Kidney Cancer
Michael R. Harrison, MD Associate Professor of Medicine Duke University Medical Center Duke Cancer Institute discusses Combinations In Anti VEGF Kidney Cancer. At Kidney Cancer Association National Pa...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
VEGF Inhibitors In Adjuvant Kidney Cancer
Naomi B Haas MD Director of Kidney and Prostate Cancer Clinical Programs Abramson Cancer Center discusses VEGF Inhibitors In Adjuvant Kidney Cancer. At Kidney Cancer Association National Patient Septe...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
The Allure To The Immune Checkpoint Inhibitors
Naomi B Haas MD Director of Kidney and Prostate Cancer Clinical Programs Abramson Cancer Center discusses The Allure To The Immune Checkpoint Inhibitors. At Kidney Cancer Association National Patient ...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
ASSURE, S-TRAC, ATLAS, & PROTECT Trials
Naomi B Haas MD Director of Kidney and Prostate Cancer Clinical Programs Abramson Cancer Center discusses ASSURE, S-TRAC, ATLAS, & PROTECT Trials. At Kidney Cancer Association National Patient Septemb...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Only 3% Of Cancer Patients Participate In Clinical Trials
Susan Demo, Ph.D Calithera Biosciences discusses Only 3% Of Cancer Patients Participate In Clinical Trials at Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on Septe...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Kidney Cancer First Line Treatment
Mayer Fishman, MD PhD Dept. of GU Oncology Moffitt Cancer Center Dept. of Oncologic Sciences, USF Morsani College of Medicine discusses Kidney Cancer First Line Treatment at Kidney Cancer Association ...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Best Way For A Patient To Find A Clinical Trial.
Susan Demo, Ph.D Calithera Biosciences Discusses the Best Way For A Patient To Find A Clinical Trial. At Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL on September ...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
What Does PDL Positivity Mean On Biopsy?
Matt Campbell MD, MS Assistant Professor Department of Genitourinary Medical Oncology UT MD Anderson Cancer Center Discusses What Does PDL Positivity Mean On Biopsy? At Kidney Cancer Association Natio...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
When Should A Patient Receive Immunotherapy?
Matt Campbell MD, MS Assistant Professor Department of Genitourinary Medical Oncology UT MD Anderson Cancer Center Discusses When Should A Patient Receive Immunotherapy? At Kidney Cancer Association N...
Author: kidneycancer
Added: 10/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 5, 2018 Category: Cancer & Oncology Source Type: podcasts
Where Does Kidney Cancer Spread?
Philippe E. Spiess, M.D., MS, FRCS(C), FACS Senior Member, Department of GU Oncology Senior Member, Department of Tumor Biology Assistant Chief of Surgery Moffitt Cancer Center Professor of Urology, U...
Author: kidneycancer
Added: 10/04/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 4, 2018 Category: Cancer & Oncology Source Type: podcasts
